The carboxy-terminal region of CD5 is required for c-CBL mediated TCR signaling downmodulation in thymocytes
Related Experiment Video
Updated: May 14, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
Nelly S Roa1, Diana Ordoñez-Rueda, Jesús R Chávez-Rios
1Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México, DF 04510, Mexico.
Abstract:
CD5 functions as a negative regulator of TCR signaling during thymocyte development, however, the molecular mechanisms involved in this process remain elusive. A key molecule involved in the down modulation of TCR signaling is c-Cbl, an ubiquitin ligase that physically associates with CD5. Crosslinking of TCR in thymocytes leads to ubiquitylation and lysosomal/proteasomal degradation of TCR downstream signaling effectors and CD5 itself. The present report shows that co-engagement of CD3 with CD5 enhanced c-Cbl phosphorylation, which was not affected by the deletion of the pseudo-ITAM domain of CD5, the putative binding site for c-Cbl. However, amino acids present in the carboxy-terminal region of CD5, were necessary for this effect, indicating that ITAM-independent sites were involved in the interaction of c-Cbl with CD5. The carboxy-terminal region of CD5 was also required for Vav degradation, a well-known target for c-Cbl-dependent ubiquitylation. These results support the notion that the distal cytoplasmic domain of CD5, including Y463, plays a relevant role in the downmodulation of TCR signals in thymocytes via c-Cbl.
Insights
CD5 negatively regulates T-cell receptor (TCR) signaling in thymocytes. This study reveals CD5
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- CD5 acts as a negative regulator of T-cell receptor (TCR) signaling during thymocyte development.
- The ubiquitin ligase c-Cbl is involved in downregulating TCR signaling and associates with CD5.
- TCR crosslinking induces ubiquitylation and degradation of signaling molecules and CD5.
Purpose of the Study:
- To elucidate the molecular mechanisms by which CD5 downmodulates TCR signaling.
- To investigate the role of CD5's carboxy-terminal region and c-Cbl interaction in TCR signal regulation.
Main Methods:
- Co-engagement of CD3 and CD5 in thymocytes.
- Analysis of c-Cbl phosphorylation and Vav degradation.
- Site-directed mutagenesis of CD5, including deletion of the pseudo-ITAM domain.
Main Results:
- Co-engagement of CD3 and CD5 enhanced c-Cbl phosphorylation in an ITAM-independent manner.
- The carboxy-terminal region of CD5, not the pseudo-ITAM domain, was crucial for c-Cbl phosphorylation.
- CD5's carboxy-terminal region was essential for Vav degradation, a c-Cbl target.
Conclusions:
- The distal cytoplasmic domain of CD5, including Y463, plays a significant role in downmodulating TCR signals.
- This downmodulation occurs via interaction with c-Cbl, independent of CD5's pseudo-ITAM domain.
- CD5 utilizes c-Cbl-mediated ubiquitylation pathways to regulate TCR signaling during thymocyte development.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
TGF - β Signaling Pathway
